Puma Biotechnology
PBYI
PBYI
87 hedge funds and large institutions have $75.2M invested in Puma Biotechnology in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 20 increasing their positions, 34 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
16% less funds holding
Funds holding: 104 → 87 (-17)
41% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 34
48% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 31
Holders
87
Holding in Top 10
1
Calls
$231K
Puts
$161K
Top Buyers
| 1 | +$869K | |
| 2 | +$670K | |
| 3 | +$619K | |
| 4 |
Morgan Stanley
New York
|
+$606K |
| 5 |
Renaissance Technologies
New York
|
+$586K |
Top Sellers
| 1 | -$4.21M | |
| 2 | -$1.31M | |
| 3 | -$682K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$653K |
| 5 |
Goldman Sachs
New York
|
-$623K |